# PTH-083 Selective monitoring of antitnf drug levels and antibodies will reduce short-term prescribing costs and provide early personalised tailoring of antitnf therapy in routine ibd practice

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pth-083-selective-monitoring-of-antitnf-drug-levels-and-antibodies-will-reduce/

## Facts

| Field | Value |
| --- | --- |
| Author Names | TA Tandiari,Ana Ibarra,Lisa Younge,Alex Allepuz,Andrew J. Thompson,Uchu Meade,Zehra Arkir,Edward Giles,Louise Langmead,JO Lindsay,Gareth Parkes,David S. Rampton |
| Citations | 1 |
| DOI | 10.1136/gutjnl-2015-309861.971 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2466750687 |
| Type | conference-abstract |
| Year | 2015 |

## Paper authors

- [Uchu Meade](https://scholariq.org/researchers/uchu-meade/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.